Long-term effects of weight-reducing drugs in hypertensive patients-Reference-Cited by-同舟云学术

Long-term effects of weight-reducing drugs in hypertensive patients

Published:2013-03-28 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Siebenhofer Andrea,Jeitler Klaus,Horvath Karl,Berghold Andrea,Siering Ulrich,Semlitsch Thomas

Publisher

John Wiley & Sons, Ltd

Reference102 articles.

1. Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension;Bakris;Journal of Hypertension,2002

2. Sufficient weight reduction decreases cardiovascular complications in diabetic patients with the metabolic syndrome: A randomized study of orlistat as an adjunct to lifestyle changes (diet and exercise);Cocco;HeartDrug,2005

3. Safety and efficacy of sibutramine in overweight Hispanic patients with hypertension;Fanghaenel;Advances in Therapy,2003

4. Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients;Faria;Diabetes, Obesity & Metabolism,2005

5. Effects of sibutramine on the treatment of obesity in patients with arterial hypertension. Portuguese, English];Faria;Arquivos Brasileiros de Cardiologia,2002

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact on Cardiovascular Health of Using Phentermine/Topiramate in Combination With Laparoscopic Sleeve Gastrectomy in Super Obesity;Journal of Surgical Research;2023-06

2. Influence of Obesity on Blood Pressure Responses to Antihypertensive Drug Therapy in an Urban Hypertension Specialty Clinic;American Journal of Hypertension;2022-06-15

3. Long-term effects of weight-reducing drugs in people with hypertension;Cochrane Database of Systematic Reviews;2021-01-17

4. The Fatty Acid Lipid Metabolism Nexus in COVID-19;Viruses;2021-01-11

5. Obesity: The New Global Epidemic Pharmacological Treatment, Opportunities and Limits for Personalized Therapy;Endocrine, Metabolic & Immune Disorders - Drug Targets;2020-10-15